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Neurobiology of Disease
Mechanisms of Primary Axonal Damage in a Viral Model of
Multiple Sclerosis
Jayasri Das Sarma,1 Lawrence C. Kenyon,2 Susan T. Hingley,3 and Kenneth S. Shindler4
Departments of 1Neurology and 2Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, 3Philadelphia
College of Osteopathic Medicine, Philadelphia, Pennsylvania 19131, and 4Scheie Eye Institute and FM Kirby Center for Molecular Ophthalmology,
University of Pennsylvania, Philadelphia, Pennsylvania 19104
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Recent studies have demonstrated that significant axonal
injury also occurs in MS patients and correlates with neurological dysfunction, but it is not known whether this neuronal damage is a
primary disease process, or occurs only secondary to demyelination. In the current studies, neurotropic strains of mouse hepatitis virus
(MHV) that inducemeningitis, encephalitis, and demyelination in the CNS, an animalmodel ofMS,were used to evaluatemechanisms of
axonal injury. The pathogenic properties of genetically engineered isogenic spike protein recombinant demyelinating and nondemyeli-
nating strains of MHV were compared. Studies demonstrate that a demyelinating strain of MHV causes concomitant axonal loss and
macrophage-mediated demyelination. The mechanism of axonal loss and demyelination in MHV infection is dependent on successful
transport of virus from gray matter to white matter using the MHV host attachment spike glycoprotein. Our data show that axonal loss
and demyelination can be independent direct viral cytopathic events, and suggest that similar direct axonal damage may occur in MS.
These results have important implications for the design of neuroprotective strategies for CNS demyelinating disease, and our model
identifies the spike protein as a therapeutic target to prevent axonal transport of neurotropic viruses.
Introduction
The primary target in multiple sclerosis (MS) pathology is be-
lieved to be either myelin itself or the myelin-forming cell, the
oligodendrocyte. Axonal damage described in early literature
drew little attention because it was regarded as secondary to my-
elin injury (Kornek et al., 2000). Recently, there has been critical
reappraisal of axonal damage in MS as gray matter involvement
(Sharma et al., 2001) and axonal injury in white matter were
reported (Lovas et al., 2000; Bjartmar et al., 2001). Axonal injury
is likely irreversible and a major component of MS (Ferguson et
al., 1997; Trapp et al., 1998, 1999), but it is not known whether
axonal injury occurs exclusively secondary to myelin damage, or
concomitantlywithmyelin damage fromadirect neuronal insult.
Mechanisms of axonal damage in MS are essentially unknown,
although evidence suggests it may not be entirely immune medi-
ated (Lucchinetti et al., 2001).
Axonal damage occurs in several viral infections, including
human immunodeficiency virus (An et al., 1997; Raja et al.,
1997), human T-lymphotropic virus (Iwasaki, 1990), and herpes
simplex virus (Martin, 1984), as well as Theiler’s murine enceph-
alomyelitis virus (TMEV) (Tsunoda and Fujinami, 2002;
Tsunoda et al., 2003), whose infection has been associated with
MS or animalmodels ofMS. Some neurovirulent viruses, includ-
ing herpes simplex, rabies, influenza and Borna viruses, can be
anterogradely or retrogradely transported in axons (Kristensson,
1996;Mori andKimura, 2001) leading to axonal degeneration. In
TMEV infection, axonal injury is accompanied by oligodendrocyte
apoptosis that precedes demyelination, implying that axonal injury
can trigger demyelination. Viral-induced models of demyelinating
disease therefore provide paradigms for advancing our understand-
ing of the relationship between demyelination and axonal loss.
Infection of mice with neurotropic strains of mouse hepatitis
virus (MHV) induces meningoencephalitis, followed by chronic
inflammatory demyelination (Lavi et al., 1984). MHV was be-
lieved to primarily cause demyelination, with relative axonal
preservation. However, some axonal damage was recently ob-
served (Dandekar et al., 2001) in an adoptive-transfer model of
neurovirulent strain MHV-JHM. We observed that a related
strain (MHV-A59) induces axonal loss in optic nerve, in contrast
toMHV-2, a nondemyelinating (NDM)MHV strain (Shindler et
al., 2008). These observations raise the question of whether ax-
onal loss induced by demyelinating (DM) strains could be a pri-
mary pathology rather than only secondary to demyelination,
and molecular mechanisms mediating this axonal loss are not
known. To further investigate mechanisms of axonal degenera-
tion, we compared ultrastructural pathology of recombinantDM
and NDMMHV strains.
Our studies reveal that infection with RSA59, a DM strain con-
taining MHV-A59 recombined with its wild-type A59 spike gene,
causes axonal loss concurrent with macrophage-mediated demy-
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elination. In contrast, spinal cord infected with RSMHV2, a
NDM strain containing the MHV2 spike gene in the MHV-A59
genome, shows only rare early axonal degeneration. Results sug-
gest that mechanisms mediating both demyelination and axonal
loss are dependent on spike-mediated axonal transport of viral
particles from gray matter to white matter, and suggest axonal
loss can occur due to direct viral attack in addition to, or rather
than, occurring secondary to demyelination.
Materials andMethods
Viruses.Recombinant isogenicDMstrainofMHV,RSA59, andNDMstrain
RSMHV2 were used from our previous studies (Das Sarma et al., 2002,
2008). RSA59 and RSMHV2 strains of MHV are isogenic (background is
from demyelinating strain of MHV; MHV-A59) except for the spike gene,
whichencodesaglycoproteinexpressedonthevirionenvelope thatmediates
many biological properties of MHV, including receptor attachment, fu-
sion of viral and cell membranes during entry, cell-to-cell fusion
during viral spread, and immune activation (Cavanaugh, 1995). These
recombinant strains also express enhanced green fluorescence protein
(EGFP).
Inoculation of mice. Four-week-old, MHV-free, C57BL/6 (B6) mice
(Jackson Laboratory) were inoculated intracranially with 50% LD50 dose
of RSA59 strain (20,000 pfu) or RSMHV2 (100 pfu) as described previ-
ously (Das Sarma et al., 2002, 2008). Mice were monitored daily for
mortality and signs of disease. Mock-infected controls were inoculated
similarly but with an uninfected cell lysate at a comparable dilution. All
experimental procedures were approved by the Institutional Animal
Care and Use Committee.
Histopathological analysis. Mice were killed
at the peak of inflammation (day 7) and/or day
30 postinoculation (p.i.), and were perfused
transcardially with PBS followed by PBS con-
taining 4% paraformaldehyde (PFA). Liver,
brain, and spinal cord tissues were collected,
postfixed in 4% PFA overnight and embedded
in paraffin. Brain and spinal cord tissues were
sectioned at 5 m and stained with either he-
matoxylin/eosin (H&E) for evaluation of in-
flammation, Luxol Fast Blue (LFB) to detect
demyelination, or Bielchowsky silver impreg-
nation (Czasch et al., 2006) for loss of axons.
Experiments were repeated three times with
3–5 mice in each group. Areas of demyelina-
tion were quantified using a 0–3 point scale as
described earlier (Shindler et al., 2008), where
0  no demyelination; 1  rare foci of demy-
elination; 2 a few foci of demyelination; and
3  large (confluent) areas of demyelination.
Briefly, two sections were examined from each
of three spinal cord levels (cervical, thoracic
and lumbar) for each mouse. All slides were
coded and read in a blinded manner. Demyeli-
nation was scored based on detection of focal
white matter areas lacking LFB staining using
the relative three-point scale.Differences in de-
gree of demyelination between groups were
compared by Wilcoxon signed-rank test. To
further quantify the level of demyelination at
its peak 30 d postinoculation, identical sections
of LFB-stained spinal cords from selected
RSA59- and RSMHV2-infected mice were dig-
itally scanned and analyzed on an Aperio Scan-
scope XT slide scanner and Aperio Imagescope
version 10.0.36.1805 software (Aperio). A line
was drawn surrounding all white matter re-
gions on each slide, and the software was used
to calculate the total area of white matter.
Within the white matter, the combined area of
foci that did not stain with LFB was also calcu-
lated, and were divided by the total white matter area to express the
percentage of spinal cord white matter that was demyelinated.
To confirm expected virulence of the strains used, livers from the
infectedmice were embedded in paraffin, sectioned at 5m, and stained
with H&E (Das Sarma et al., 2000; Navas et al., 2001).
Immunohistochemical analysis. Serial sections from spinal cords were
stained by the avidin–biotin–immunoperoxidase technique (Vector
Laboratories) using 3, 3-diaminobenzidine as substrate, and a 1:100
dilution of anti-CD45 (LCA; leukocyte common antigen, LY-5, BD
PharMingen), anti-CD11b (OX42; Santa Cruz Biotechnology), or CD3
(PC3/188A; Santa Cruz) as primary antibodies. Control slides from
mock-infected mice were incubated in parallel. To quantify the level of
inflammation in spinal cord sections, LCA staining was scored by a
blinded investigator as either absent (no staining), mild (few scattered
LCA cells), moderate (1–2 plaques of inflammatory cells), or severe (3
or more inflammatory plaques). Presence of moderate or severe inflam-
mation was compared between groups by Fisher’s exact test.
Ultrastructural studies.To further characterize the preservation ofmy-
elin and axons, mice were anesthetized, perfused with 4% PFA, and
spinal cords were harvested and fixed overnight in 2% glutaraldehyde.
Samples for transmission electron microscopy (TEM) were postfixed
with 1% osmium tetroxide, dehydrated, and flat embedded in Poly-Bed
812 epoxy resin (Polysciences). Half-micrometer-thick sections were cut
from the lesional epicenter, stainedwith toluidine blue, and examined by
light microscopy. Ultrathin TEM sections (600 Å) were cut from repre-
sentative foci of demyelination from the toluidine blue-stained semithin
sections and mounted on 200 mesh copper grids, stained with uranyl
acetate and bismuth subnitrite, and viewed under a JEOL JEM 1010
Figure 1. Characterization of inflammatory cells present during acute infectionwith RSA59 and RSMHV2 inmouse brain. Serial
sagittal sections (5m thick) of brain from DM (RSA59) (A, C, E)- and NDM (RSMHV2) (B, D, F )-infected mice at day 7 p.i were
immunostained for LCA (A–D) or CD11b (E,F ). LCA staining shows acute encephalitis in DM-infectedmouse brain characterized by
the presence of inflammatory infiltrates throughout the parenchyma in laser-scanned images (A) and at high magnification (C),
with similar encephalitis in NDM-infected brain (B, D). The majority of LCA inflammatory cells stained positive for the macro-
phage/microglia marker CD11b in both DM (E)- and NDM (F )-infected mouse brain. A and B are laser-scanned images of glass
slides. Original magnifications for C–F are 100.
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electron microscope. Images were acquired
with a Hamamatsu Orca-1 CCD camera and
AMT Advantage Digital image Capturing soft-
ware. Ultrathin sections were made from 5 mice
from one cohort of RSA59- and RSMHV2-
infectedmice.
Detection of viral antigen spread by EGFP.Cryo-
stat sections were prepared from day 7 p.i. mice
(Das Sarma et al., 2008). To detect EGFP fluores-
cence without immunostaining, brain and spinal
cord cryostat sections were fixed in ice-cold 95%
ethanol for 20 min, incubated in ice-cold
PBS for 10min, and thenmounted in Vectash-
ield mounting medium (Vector Laboratories).
Sections were visualized using an Olympus
X-80 microscope system with a 10 long-
working distance UPlanF1 phase objective and
a filter pack suitable for green fluorescence. Ex-
periments were repeated in triplicate.
Isolationofprimaryneuronal cells.Primaryhip-
pocampal neurons were obtained fromday 14 to
day 16 embryonic C57BL/6 mice as previously
reported (Pasick et al., 1994; Rall et al., 1997).
Purity of isolated neuronal cells was determined
by double-label immunofluorescence with neu-
ronal marker anti-MAP2b and astrocyte marker
anti-GFAP (glial fibrillary acidic protein).
Infection of primary neuronal cells with
EGFP-tagged MHVs. On day 4 after explanta-
tion, neuronal cultures were infected at a mul-
tiplicity of infection (MOI) of 2:1 with RSA59
and RSMHV2 or mock infected with nonin-
fected cell lysate. After allowing viral absorp-
tion for 1 h, cells were washed and placed in
freshmediawithout virus. At 0, 24, 36, and 48 h
after infection, cultures were examined by mi-
croscopy for EGFP fluorescence.
Results
Comparative inflammatory CNS
pathology of DM versus NDM strains
To characterize viral-induced CNS in-
flammation, mice were inoculated with
RSA59 (DM) or RSMHV2 (NDM) and
7 d p.i. (peak inflammation) brain and
spinal cord sections stained with H&E or
LFB were examined. RSA59 inducedmen-
ingitis, encephalomyelitis, hepatitis, and de-
myelination,whereasRSMHV2causedonly
meningitis, encephalomyelitis, and hepati-
tis, but not demyelination, as shown previ-
ously (Das Sarma et al., 2000, 2008).
To characterize inflammatory cell types,
brain sections from mice, day 7 p.i.,
were stained immunohistochemicallywith
anti-CD45 (LCA; leukocyte common an-
tigen), anti-CD11b (macrophage/micro-
glial marker), or anti-CD3 (pan T-cell
marker). The majority of inflammatory
cells in either DM- or NDM-infected
brains were immunoreactive for both
LCA (Fig. 1A–D) and CD11b (Fig. 1E,F). Some CD3-stained
infiltrating T cells were also found (data not shown), although
nonspecific background staining of neurons with available
anti-CD3 antibodies made quantification difficult. Together,
the data indicate that DM- and NDM-induced CNS inflam-
mation consists of a mixed population of inflammatory cells,
predominantly macrophages/microglia as well as a smaller
population of T lymphocytes.
Pathology was also assessed in cross sections from each spinal
cord level at day 7 (peak inflammation) and day 30 (peak demy-
Figure 2. Demyelination and axonal loss in DM- and NDM-infected mouse spinal cord. Serial cross sections (5m thick) from
DM-andNDM-infectedmouse spinal cordatday7p.i.were stained formyelinwith LFB (A,C) or byBielchowsky silver impregnation
(B,D).A, A large demyelinating plaque observed in DM-infectedmouse spinal cord is shown (arrow indicates demyelinated area).
B, In an adjacent section, the same demyelinating plaque of DM-infected spinal cord showed loss of axons (arrow indicates area of
axonal loss). C, Normal myelin was observed in NDM-infected mouse spinal cord. D, No axonal loss was observed in the NDM-
infected mouse spinal cord. Original magnification for A–D is 40.
Figure 3. Toluidine blue-stained sections delineate preservation of myelin, axons, and axon–myelin coherence following DM
andNDM infection. Spinal cord sections (1mthick) ofmice killed 30 d p.i. with DMandNDMwere stainedwith toluidine blue.A,
B, Large demyelinated plaqueswere observed in DM-infectedmouse spinal cord.Myelinated spinal cordwhitematter region (M),
demyelinated region of spinal cord white matter (D), gray matter (G), and macrophages (M) are marked. C, D, In NDM-infected
mouse spinal cord, myelin remains relatively preserved with rare examples of early axonal degeneration characterized by loss of
the central axon and collapse of themyelin sheath (arrows). Originalmagnification forA and C is 100 and forB andD is 1000.
10274 • J. Neurosci., August 19, 2009 • 29(33):10272–10280 Das Sarma et al. • Axonopathy in MHV Infection
elination) p.i. Similar to brain, both DM and NDM strains in-
duced meningitis and myelitis (data not shown). Demyelinating
plaques were detected by LFB stains for myelin (Das Sarma et al.,
2008) at day 7 p.i. in DM-infected mice (Fig. 2A), and were
quantified on a 0–3 scale (Shindler et al., 2008). Day 30 p.i. tissue
sections from DM-infected mice showed a similar pattern of de-
myelination as on day 7, but the number and area of plaques was
larger (see Fig. 7A). NDM-infected mice did not exhibit any de-
myelination either at day 7 (Fig. 2C) or at day 30 p.i. [average
demyelination score/section  0.0; n  9 mice (54 sections) at
day 7 and 10 mice (60 sections) at day 30
from 3 experiments]. Significant demyeli-
nation was detected in spinal cords from
DM-infected mice at both day 7 [average
demyelination score 0.81 0.52 (mean
SD); n 9 mice (54 sections); p 0.0001
vs NDM-infected mouse spinal cords]
and day 30 [1.88 0.68; n 14 mice (84
sections); p  0.0001]. To further quan-
tify the extent of demyelination, spinal
cord sections from 3NDM-infected and 3
DM-infected mice killed at day 30 p.i.
were randomly selected for digital image
analysis to measure the percentage of spi-
nal cord white matter lacking LFB myelin
staining. On average, spinal cord sections
fromDM-infected mice (n 18 sections)
had a significantly higher cumulative area
of demyelination, covering 13.89 
11.9% (mean  SD) of all white matter
regions, compared with NDM-infected
mouse spinal cords that had no (0.0%)
detected demyelination ( p 0.0003).
To avoid high mortality following
NDM-induced hepatitis, we used 50% of
the LD50 dose (100 pfu). In previous exper-
iments, we ensured that the DM strain even
at 5 and 50 pfu produced demyelination in
100%of infectedmice; however, therewas a
reduction in the size and quantity of demy-
elinating plaques compared with a 50%
LD50 dose (Das Sarma et al., 2000).
Results show demyelination begins as
early as day 7 p.i., indicating that DM-
induced myelin damage begins during an
early stage of acute inflammation, a find-
ing not evident from earlier studies.
Significant axonal loss occurs following
RSA59 infection
Though MHV-induced demyelination is
characteristically described as sparing axons
within areas of demyelination, we recently
observed axonal loss with demyelination in
the optic nerve of MHV-A59 (parental
DM)-infected mice (Shindler et al., 2008).
This led us to hypothesize that DM MHV
may induce axonal loss in the spinal cord.
To examine this, serial sections of spinal
cords from RSA59 (DM)- and RSMHV2
(NDM)-infectedmice were stained by Biel-
chowsky silver impregnation. DM-infected
spinal cord sections at both day 7 and day
30 p.i. showed a significant decrease of axonal staining (Fig. 2B). No
axonal loss was evident in the NDM-infected mouse spinal cords
either at day 7 (Fig. 2D) or at day 30 p.i. (data not shown).
To further evaluate the loss and/or preservation ofmyelin inDM
andNDM-induced inflammatoryplaques, semithin spinal cord sec-
tions cut at 1mintervals from five infectedmice at day 30 p.i. were
stained with toluidine blue. Control mock-infected mouse spinal
cord was used to evaluate for background fixation and/or postfix-
ation artifacts. DM-infected spinal cords showed significant myelin
loss within plaques (Fig. 3A). Moreover, high-magnification im-
Figure 4. Electron micrographic analysis of demyelination and axonal loss in DM- and NDM-infected mouse spinal cord. Rep-
resentative foci of demyelination and axonal injury were selected from the toluidine blue-stained sections shown in Figure 3 and
processed for electronmicroscopy.A, Normalmorphology ofmyelinated axonswas exhibited fromanonplaque region adjacent to
a demyelinated plaque of DM-infectedmouse spinal cord. B–D, Demyelinating plaque in DM-infectedmouse spinal cord showed
extensive loss of myelin, hypomyelination (arrows), complete axonal degeneration with only residual empty vacuoles (arrow-
heads), naked axons with no myelin sheath at all (*), and macrophages (M). E, A high-magnification image (120,000) of a
naked axon surrounded only by a single lipid bilayer shows preservation of cytoskeletal elements (microtubules and intermediate
filaments). F, In contrast, NDM-infected mouse spinal cords show only rare examples of early axonal degeneration. This electron
micrograph corresponds to a similar collapsed degenerating fiber seen in Figure 3D.marks an oligodendrocyte nucleus. Such
early axonal degenerationwas not observed inmock-infectedmice. Original magnifications: A, 3000;B, 5000; C, 6000;D,
3000; E, 120,000; and F, 6000.
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ages showed infiltrating macrophages
filled withmyelin debris (Fig. 3B). In con-
trast, in NDM strain RSMHV2-infected
spinal cord sections, myelin is almost
completely preserved, with only rare ex-
amples of early axonal degeneration,
characterized by loss of the central axon
and collapse of the myelin sheath (Fig.
3C,D). The presence of this focal axonal
degeneration was not detectable in prior
studies of paraffin embedded tissues by
silver impregnation.
High-resolution electronmicrographic
analysis confirms axonal loss
concurrent with demyelination in
RSA59-infected mouse spinal cord
To further characterize axonal pathology
at the ultrastructural level, representative
foci of demyelination and axonal injury
were selected from toluidine blue-stained
sections, and 600 Å ultrathin sections
from Poly-Bed embedded blocks were
processed for TEM.High-resolutionTEM
images show a combination of axonal de-
generation and demyelination. There is
extensive axonal loss and many residual
empty vacuoles corresponding to totally
degenerated fibers. In addition, there are
numerous hypomyelinated fibers and na-
ked axons without any myelin sheath, in-
dicative of a demyelinating process (Fig.
4B–D). These naked axons are fully in-
tact with surrounding axolemmas and
axoplasm with preserved microtubules
and intermediate filaments (Fig. 4E).
Importantly, for the first time, one
mechanism of demyelination was re-
vealed as macrophage-mediated myelin
stripping. This is demonstrated in Figure
5 in which a macrophage is observed sur-
rounding a myelinated axon. The myelin
is unraveling, yet the axon is completely
intact. At the inner border of the myelin
sheath, multiple vacuoles are present as
the entire myelin sheath is lifting off the
axon. The macrophage cell membrane is
in intimate contact with the outer por-
tion of the myelin sheath as the macro-
phage strips away and engulfs the
myelin sheath. Multiple vacuoles with
myelin fragments are seen within the cy-
toplasm of the macrophage. In contrast,
NDM-infected mouse spinal cords dem-
onstrate no appreciable axonal loss andno
features of demyelination. Specifically,
there are no hypomyelinated fibers, no
naked axons, nomacrophages, and no ev-
idence of macrophage-mediated myelin
stripping. Instead, there are only rare examples of early axonal
degeneration characterized by loss of the central axon and col-
lapse of themyelin sheath (Fig. 4F) as previously seen in toluidine
blue-stained sections (Fig. 3D).
Spinal cord inflammatory plaques contain
predominantly macrophages
To characterize inflammatory cells within spinal cord plaques,
serial sections from DM- and NDM-infected mice were stained
Figure 5. Macrophage-mediatedmyelin stripping inDM-induceddemyelinatingplaque.A, Amacrophage (upperportionof figure) is
observedsurroundingan intactaxon(lowerportionof figure)withuncompactedmyelin.Myelin figuresareobservedwithinthecytoplasm
ofthismacrophageindicativeofpriorengulfmentofmyelin.B,Highermagnificationdemonstratescloseappositionofthemacrophagecell
membraneandanouter layerofuncompactedmyelin.Theaxoplasmandaxolemmaare intactandtheadjacentmyelinshowsvesiculation
indicative ofmyelin degeneration. Originalmagnification forA is 15,000 and forB is 40,000.
Figure6. Distribution of inflammatory cells in the graymatter versuswhitematter inDM- andNDM-infectedmouse spinal cord
during acute infection. Serial cross sections (5mthick) fromDM- andNDM-infectedmouse spinal cords at day 7 p.i. were stained
with H&E (A, B), LCA (C, D), or CD11b (E, F ). Several inflammatory lesions (A) with infiltrating LCA cells (C) were observed in
RSA59-infectedmouse spinal cord (arrows indicate lesional areas inwhitematter). ThemajorityoftheLCA inflammatorycells inthe
inflammatory plaques were positive for the microglia/macrophage marker CD11b (E). CD11b cells in DM-infected mice are predomi-
nantly inthewhitematter. InNDM-infectedmice,nodiscreteinflammatorylesionswereobserved(B);however,LCAcellswereobserved
(D) scattered throughout the gray matter. These cells were also strongly immunoreactive for CD11b (F ). Most of the LCA/CD11b-
immunoreactive cellswere restricted to graymatterwith very little invasion ofwhitematter. Originalmagnification forA–F is 40.
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with anti-CD45 (LCA), anti-CD11b, or anti-CD3. LCA staining
confirmed the presence of infiltrating inflammatory cells (Fig.
6C,D). Interestingly, the distribution of LCA cells was signifi-
cantly different after infection by the two viral strains. At day
7 p.i., the majority of infected cells in RSA59-infected spinal cord
were localized to whitematter with only occasional infiltration of
gray matter (Fig. 6C), whereas in RSMHV2-infected spinal cord,
LCA cells were mainly restricted to gray matter (Fig. 6D).
CD11b staining demonstrated that the majority of LCA cells in
the spinal cord were CD11b (Fig. 6E,F), similar to brain (Fig.
1E,F). Some CD3-stained infiltrating T cells were also present
(data not shown), although quantification of CD3-immunoreactive
cellswas limitedbynonspecificbackgroundstainingsimilar tobrain.
At day 30 p.i., LCA cells were still present in abundance in demy-
elinating plaques produced followingDM infection (Fig. 7A,C) but
in NDM-infectedmice, no demyelinating plaques were present and
very few LCA cells were retained in the gray matter (Fig. 7B,D).
Together, immunohistochemical datademonstrate that inDM-and
NDM-strain-infected spinal cord there is an increase of LCA/
CD11b cells; however, the distribution of these inflammatory cells
is significantly different between the two strains.
DM and NDM strains differ in neuronal intracellular
distribution of viral antigen
To determine whether differential localization of viral antigen is
responsible for the observed distribution of inflammatory cells,
cross sections from spinal cord of DM- and NDM-infected mice
were examined. Since the DM and NDM viruses used in these
studies express EGFP, viral distribution was assessed directly by
fluorescence microscopy. On day 7 p.i., the DM fluorescence was
mainly restricted to white matter (Fig. 8A,B) with limited involve-
ment of gray matter, whereas NDM fluorescence was restricted to
graymatter (Fig. 8C,D). High-magnification fluorescence images in
brain from day 7 p.i. demonstrate numerous viral antigen-positive
neurons and their axons following DM infection (Fig. 8E), whereas
far fewer fluorescent neurons and axons are observed following
NDM infection (Fig. 8F).
The ability of DM and NDM to repli-
cate and spread in vitro was compared
using primary hippocampal neuronal cul-
tures. Immunostaining of MAP2b and
GFAP demonstrated that cultures con-
sisted primarily of neurons with 5% of
cells exhibiting GFAP immunoreactivity
(data not shown). At 12 h intervals, from0
to 72 h p.i., cultures were monitored for
viral antigen spread by fluorescence mi-
croscopy. At 24 h p.i. several infected cells
were observed in DM-infected cultures
(Fig. 8G), whereas, at 72 h p.i., the number
of EGFP-positive cells was significantly
increased (Fig. 8H). In contrast, NDM-
infected cultures had few discrete cells
positive for EGFP at 24 h p.i. (data not
shown), and at 72 h p.i. the viral infection
remained restricted only to the initially
infected neurons (Fig. 8 I), with little or no
spread to adjacent cells, consistent with in
vivo data.
Discussion
Results of the current studies provide im-
portant insights into the mechanisms of
demyelination and axonal damage inCNS
demyelinating diseases. Such insights are critical for designing
rational therapeutic strategies for MS and related diseases. Spe-
cifically, our results demonstrate that axonal damage can occur
concurrentlywith and independently of demyelination. This sug-
gests that direct viral-mediated axonal damage can occur as a
primary pathology, separate from the pathology of demyelina-
tion. Indeed, even the NDM strain of MHV used here lead to
early, localized neurodegenerative changes, although complete
loss of axons only occurred following infection with DM virus.
Our previous studies of MHV-induced meningoencephalo-
myelitis suggested that differential neural cell tropism may con-
tribute to neurovirulence and induction of demyelination. Both
DM and NDM strains infect neurons; however, these strains dif-
fer in their capacity to translocate to white matter as determined
by fluorescence of EGFP-tagged viral particles. The current ex-
periments indicate that axonal transport of viral particles is an
important mechanism mediating not only the extent of axonal
damage, but also the subsequent induction of demyelination in
the spinal cord. DM strain shows white matter involvement early
(by day 7 p.i.) and at later time points gray matter involvement is
essentially absent in the spinal cord, with only minimal involve-
ment in the brain. This observation further supports our earlier
findings that DM and NDM strains differ in their viral antigen
distribution during acute infection in the spinal cord (Das Sarma
et al., 2008). Evaluation of axonal loss and demyelination in the
spinal cord, where there is clear separation of gray matter and
large tracts of white matter, demonstrated that DMMHV infec-
tion begins in the neuronal cell body and propagates centripetally
to the axon (Fig. 8E–I), which subsequently induces axonal de-
generation and demyelination. NDM strains were unable to
propagate from gray to white matter and as a result, are unable to
induce demyelination.
The migration and activation of numerous CD11b macro-
phages/microglia to the white matter following viral spread of
DM MHV suggests that recruitment of these cells mediates de-
myelination. During DM strain chronic infection at day 30 p.i.,
Figure 7. Distribution of inflammatory cells in the gray matter versus white matter in DM- and NDM-infected mouse spinal
cords during chronic infection. Serial cross sections (5m thick) fromDM- or NDM-infectedmouse spinal cords at day 30 p.i. were
stainedwith LFB (A,B) or LCA (C,D). Large demyelinating lesions (A)with infiltrating LCA cells (C)were observed inDM-infected
mouse spinal cord white matter (arrows indicate lesion area) whereas normal myelin (B) was observed in NDM-infected mouse
spinal cord with only rare scattered LCA cells in the gray matter (D). Original magnification, 40.
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macrophages/microglia were still present within areas of demy-
elination, whereasmacrophages/microglia and viral antigenwere
cleared from the gray matter following NDM strain infection.
One plausible explanation is that MHV spreads intra-axonally in
an anterograde manner within gray matter and when it reaches
the white matter, viral particles are able to infect oligodendro-
cytes via direct cell–cell contact. A less likely possibility is that
infection proceeds indirectly from neurons to oligodendrocytes
by intermediary cells such astrocytes, microglia, or endothelial
cells. Regardless of the mechanism of viral spread, ultimately,
macrophages andmicroglia are recruited to the areas of infection.
In this way,MHV infection triggers axonal loss andmacrophage-
mediated demyelination. However, we also observed in NDM
strain infection, that axonal degeneration and myelin disruption
can occur in the absence ofmacrophages. Therefore,MHV infec-
tion can both directly and indirectly cause axonal loss and demy-
elination. It may be that the failure of NDM strain to trigger
macrophage-mediated damage is entirely a function of transport
failure to the white matter.
The current studies further demonstrate that the molecular
mechanisms underlying axonal damage aremediated by the spike
glycoprotein. The recombinant DM and NDM viruses used are
isogenic on a background of the DMMHV-A59 strain, and differ
only by the virus-host attachment spike glycoprotein. In vivo, the
spike protein host receptor is CEA (carcinoembryonic antigen),
which functions as an intercellular adhesion molecule (Dveksler
et al., 1993; Chen et al., 1997; Tan et al., 2002). However, there is
evidence that other viral entry host factorsmay also be permissive
for viral infection (Gallagher et al., 1992). Evidently, the differ-
ence in the spike proteins between theDMandNDMstrains does
not impair host–receptor interactions or viral entry since both
strains effectively cause encephalitis following transcranial inoc-
ulation. The spike protein does, however, appear to play a critical
role in axonal transport, as we found a lack of viral antigen spread
Figure 8. DM and NDM differ in their ability to translocate from gray matter to white matter during acute infection. DM- and NDM-infected mice were killed at day 7 p.i.; brain and spinal cord
tissues were harvested and processed for frozen sections. Cryostat sections were postfixed with 95% ice-cold ethanol for 20 min and observed by fluorescent microscopy for viral antigen (EGFP
fluorescence).A, In DM-infected spinal cord, viral antigen-positive EGFP expressing cells are present in both gray andwhitematter.B, Area of EGFP-positive cells fromA ismarked in a corresponding
LFB-stained section. C, In NDM-infectedmice, EGFP-positive cells with viral antigen are predominantly restricted to the graymatter.D, Area of EGFP-positive cells from C is marked in corresponding
LFB-stained section. E, Axonal distribution of the EGFP fluorescent viral antigen is evident in DM-infected brain. F, NDM-infected neurons in the brain show considerably reduced axonal transport of
viral antigen.G–I, To further confirm theability ofDMandNDMto infect neurons and spread fromneuron toneuron, 4-d-oldprimaryhippocampal neuronal cultureswere infectedwithDMandNDM
atMOI of 2. Representative fields containing an equivalent density of cells are shown in each image.G, At 24hp.i., DM infects a small percentage of theneurons in culture.H, By 72hp.i., DM-infected
neuronswere observed to spread fromoneneuron to thenext, as nearly all cells in the culture contain viral antigendespite initial infection of only a small percentageof cells. I, NDM-infectedneurons
on the other hand, demonstrate limited axonal transport efficiency at 72 h p.i., with only a small number of cells containing a bright concentrated signal that is retained after primary infection.
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and subsequent inflammation extending into spinal cord white
matter following infection with the NDM strain in contrast to
extensive white matter involvement secondary to DM strain in-
fection. MHV spike is synthesized as an 180 kDa glycosylated
precursor that is posttranslationally cleaved into two 90 kDa sub-
units, S1 and S2 (Frana et al., 1985), with a receptor binding
domain in the S1 subunit (Kubo et al., 1994) that is responsible
for the initial attachment of MHV to cell surface receptors.
This binding event triggers a conformational change in spike
that allows S2 to initiate fusion of the virus and host mem-
branes (Gallagher and Buchmeier, 2001; Matsuyama and
Taguchi, 2002; Zelus et al., 2003). A candidate fusion peptide
domain has been identified within S2 (Luo and Weiss, 1998);
however, the actual fusion peptide for the MHV spike has not
been definitively identified. MHV-A59 and MHV-2 spike pro-
teins have 82% amino acid sequence identity and 94% similarity,
with the S2 domain relatively more conserved and S1 more vari-
able (Spaan et al., 1988). They also differ in their cleavage signal
site whereby MHV-A59 spike is cleaved posttranslationally into
S1 and S2 subunits, but MHV-2 spike protein is not cleaved and
unable to cause fusion in vivo and in vitro (Yamada et al., 1997).
Thus, variable regions of the S1 domain or differences in the
cleavage signal site between DM and NDM strains are candidate
domains that may potentially explain the differential axonal
transport and demyelination observed in our studies and will be
evaluated further in future studies.
Together, our results demonstrate that the mechanisms of
white matter injury in this model of CNS demyelinating disease
are due to a combination of both axonal injury/loss and myelin
damage. In DM infection, there is concomitant axonal loss and
demyelination, and at least some demyelination is due to
macrophage-mediated myelin stripping. One can hypothesize
that axonal degeneration follows in this immune-mediated
pathogenesis. Partial axonal loss also appears to occur secondary
to direct viral-induced cytopathic effects, a non-immune-
mediated mechanism. Following NDM infection, although rela-
tively rare, myelinated fibers in the spinal cord white matter exhibit
early axonal degeneration in the absence of any associated inflam-
mation. Therefore, MHV infection exhibits diverse mechanisms
of axonal loss and demyelination that are both immune- and
non-immune-mediated.
While the underlyingmechanisms leading to the development
of MS in patients is not known, numerous studies have provided
evidence to suggest that a viral infectionmay trigger this autoim-
mune demyelinating disease (Herna´n et al., 2001; Hemmer et al.,
2002). The critical role of the spike glycoprotein in viral transport
and subsequent axonal and myelin damage demonstrated in the
current studies suggests that targeted disruption of the spike
glycoprotein-host interaction has the potential to prevent the
onset or progression of demyelination. Future experiments will
be geared toward identifying how the spike proteins interact with
the axonal transport system. Clues may be provided by other
human viral neurologic infections, including those caused by
such diverse viruses as herpes simplex and rabies, as they take
advantage of the axonal transport system tomaximize spread and
neurovirulence. Our experimental mouse model provides an ex-
cellent means by which the particular host–virus interactions re-
sponsible for successful axonal transport can be dissected and
clarified.
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